| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 34.3 | 32.6 | 21.5 |
| Other income | 0.7 | 0.5 | 0.4 |
| Total income | 35.0 | 33.1 | 21.9 |
| Profit before exceptional items & tax | 11.3 | 7.6 | 2.3 |
| Profit before tax | 11.3 | 7.6 | 2.3 |
| Net profit | 8.5 | 5.7 | 1.7 |
| Operating margin | 32.3% | 23.0% | 10.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +400.00% |
|---|---|
| Net profit, quarter on quarter | +49.10% |
| Revenue, year on year | +59.50% |
| Operating profit, year on year | +457.90% |
| Operating profit, quarter on quarter | +49.30% |
BSE results filing, NSE: RESONANCE. Figures extracted from the filing.
Resonance Specialties Ltd: key numbers
- Share price
- ₹200.50
- Market cap
- ₹231.5 Cr
- Revenue (annual)
- ₹90.25 Cr
- Net profit (annual)
- ₹10.40 Cr
- P/E (TTM)
- 15.9×Sector 34.1×
- Promoter holding
- 54.25%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Resonance Specialties Ltd
All →Resonance Specialties Board Meeting Date
Resonance Specialties informed BSE that its Board meeting is scheduled for 30 October 2026 to consider Q2/H1 FY27 financial results. The trading window closure was already communicated in September.
Resonance Specialties Other Announcement
Resonance Specialties Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Resonance Specialties Annual General Meeting
Resonance Specialties' postal ballot passed a related-party slump-sale purchase. The resolution to buy KPLL's Mandideep facility for Rs.29.98 crore carried 99.82% support.
- Value
- ₹29.98 Cr
Resonance Specialties Credit Rating
Resonance Specialties received a credit rating reaffirmation of 'CRISIL BBB-/Stable' for its bank loan facilities totaling Rs 14 Crore.
- Value
- ₹14.00 Cr
Resonance Specialties Annual General Meeting
Resonance Specialties Limited seeks shareholder approval via postal ballot for the Rs. 29.98 Crore slump sale acquisition of Kaygee Laboratories' Mandideep manufacturing facility.
- Value
- ₹29.98 Cr
Resonance Specialties Other Announcement
Resonance Specialties Limited submitted its quarterly shareholding pattern for the period ended December 31, 2025, as required by SEBI regulations.